| 摘要 |
<p>The present invention is directed to pyrrolidine compounds of the formula (I): (wherein R?1, R2, R3, R4c, R4d, and R4f¿ are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modualtors of the chemokine receptors CCR-3 and/or CCR-5.</p> |
